KERALLA G HANNA

Allopathic & Osteopathic Physicians|Internal Medicine BRONX, NY NPI 1104400860

General Payments — all program years on this page

$2,146.39

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 71
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,090.07 across 38 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,090.0738

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $21.501
2022 $527.7415
2023 $507.0817
2024 $1,090.0738

Records — PY2024 (38)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1101520568 E.R. Squibb & Sons, L.L.C. $42.94 11/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101520581 E.R. Squibb & Sons, L.L.C. $42.75 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104381549 AstraZeneca Pharmaceuticals LP $24.20 05/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104418913 AstraZeneca Pharmaceuticals LP $29.35 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104555776 AstraZeneca Pharmaceuticals LP $31.21 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104650919 AstraZeneca Pharmaceuticals LP $27.02 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105330349 AstraZeneca Pharmaceuticals LP $27.60 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105454401 AstraZeneca Pharmaceuticals LP $28.17 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105529612 AstraZeneca Pharmaceuticals LP $22.55 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105800579 AstraZeneca Pharmaceuticals LP $0.79 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105894590 AstraZeneca Pharmaceuticals LP $22.02 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118904927 Otsuka America Pharmaceutical, Inc. $25.04 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120220669 EMD Serono, Inc. $29.66 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120221761 EMD Serono, Inc. $9.19 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120221823 EMD Serono, Inc. $27.93 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120222313 EMD Serono, Inc. $31.07 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120244673 EMD Serono, Inc. $44.10 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120252870 EMD Serono, Inc. $29.13 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120264067 EMD Serono, Inc. $20.33 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150814992 Neurocrine Biosciences, Inc. $39.71 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150815250 Neurocrine Biosciences, Inc. $39.38 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150815756 Neurocrine Biosciences, Inc. $38.86 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150816540 Neurocrine Biosciences, Inc. $37.59 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150816570 Neurocrine Biosciences, Inc. $37.56 07/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150816670 Neurocrine Biosciences, Inc. $37.43 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150818238 Neurocrine Biosciences, Inc. $35.76 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150818550 Neurocrine Biosciences, Inc. $35.42 07/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150827156 Neurocrine Biosciences, Inc. $29.42 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150829938 Neurocrine Biosciences, Inc. $28.28 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150832452 Neurocrine Biosciences, Inc. $27.53 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150834662 Neurocrine Biosciences, Inc. $26.70 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151657836 Teva Pharmaceuticals USA, Inc. $28.95 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151657840 Teva Pharmaceuticals USA, Inc. $4.06 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151657862 Teva Pharmaceuticals USA, Inc. $34.58 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151657890 Teva Pharmaceuticals USA, Inc. $30.49 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151657894 Teva Pharmaceuticals USA, Inc. $3.94 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151657897 Teva Pharmaceuticals USA, Inc. $23.94 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151657901 Teva Pharmaceuticals USA, Inc. $35.42 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.